Cargando…

Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease

The concept of repurposing previously approved medications to the treatment of new indications by taking advantage of off-target effects has gained traction in recent years, particularly in areas of medicine that do not offer large profits to pharmaceutical firms. As infectious disease discovery res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montoya, Marhiah C., Krysan, Damian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2018
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299222/ https://www.ncbi.nlm.nih.gov/pubmed/30563895 http://dx.doi.org/10.1128/mBio.02272-18

Ejemplares similares

Structure-Activity Relationships for the Antifungal Activity of Selective Estrogen Receptor Antagonists Related to Tamoxifen
por: Butts, Arielle, et al.
Publicado: (2015)

Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer
por: Tecalco-Cruz, Angeles C, et al.
Publicado: (2018)

Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer’s disease
por: Wang, Xuechen, et al.
Publicado: (2022)

The Role of Macrophage Polarization in Infectious and Inflammatory Diseases
por: Labonte, Adam C., et al.
Publicado: (2014)

The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry
por: Neu, Ursula, et al.
Publicado: (2009)

The Threat and Response to Infectious Diseases (Revised)
por: Brower, Jennifer L.
Publicado: (2016)

Minireview: The Year in Review of Estrogen Regulation of Metabolism
por: Clegg, Deborah J.
Publicado: (2012)

Leveraging Immunopeptidomics To Study and Combat Infectious Disease
por: Leddy, Owen K., et al.
Publicado: (2021)

Forty Years of Molecular Diagnostics for Infectious Diseases
por: Schmitz, Jonathan E., et al.
Publicado: (2022)

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
por: Casadevall, Arturo, et al.
Publicado: (2021)

Genome-wide association studies are coming for human infectious diseases
por: Davila, Sonia, et al.
Publicado: (2009)

Infectious causes of cancer and their detection
por: Dalton-Griffin, Lucy, et al.
Publicado: (2009)

A Look Inside: Oral Sampling for Detection of Non-oral Infectious Diseases
por: Valinetz, Ethan D., et al.
Publicado: (2021)

Preserve a Voucher Specimen! The Critical Need for Integrating Natural History Collections in Infectious Disease Studies
por: Thompson, Cody W., et al.
Publicado: (2021)

SHERLOCK and DETECTR: CRISPR-Cas Systems as Potential Rapid Diagnostic Tools for Emerging Infectious Diseases
por: Mustafa, Mujahed I., et al.
Publicado: (2021)

Acute acalculous cholecystitis due to infectious causes
por: Markaki, Ioulia, et al.
Publicado: (2021)

Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo
por: Butts, Arielle, et al.
Publicado: (2014)

Making the Leap from Research Laboratory to Clinic: Challenges and Opportunities for Next-Generation Sequencing in Infectious Disease Diagnostics
por: Goldberg, Brittany, et al.
Publicado: (2015)

Toward the Development of a Circulating Free DNA-Based In Vitro Diagnostic Test for Infectious Diseases: a Review of Evidence for Tuberculosis
por: Fernández-Carballo, B. Leticia, et al.
Publicado: (2019)

Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza
por: Seki, Masafumi
Publicado: (2021)

Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing
por: Taylor, Lewis, et al.
Publicado: (2014)

Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment
por: Lashgari, Naser-Aldin, et al.
Publicado: (2021)

Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta‐analysis
por: Hellfritzsch, Maja, et al.
Publicado: (2019)

Montezuma’s revenge - the sequel: The one-hundred year anniversary of the first description of “post-infectious” irritable bowel syndrome
por: Riddle, Mark S, et al.
Publicado: (2018)

Current position of 5HT(3) antagonists and the additional value of NK(1) antagonists; a new class of antiemetics
por: de Wit, R
Publicado: (2003)

Associations between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: A Review
por: Montoya, Marhiah C., et al.
Publicado: (2021)

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
por: Aapro, M, et al.
Publicado: (2012)

5-HT(3) Receptors
por: Lummis, Sarah C. R.
Publicado: (2012)

Estrogen alpha receptor antagonists for the treatment of breast cancer: a review
por: Sharma, Deepika, et al.
Publicado: (2018)

Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2023)

New treatment modalities in Alzheimer's disease
por: Koseoglu, Emel
Publicado: (2019)

Food as Treatment of Inflammatory Bowel Diseases
por: Maldonado-Contreras, Ana
Publicado: (2022)

Immunoglobulin E Receptor Signaling and Asthma
por: Wu, Lawren C.
Publicado: (2011)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
por: Leowattana, Wattana
Publicado: (2021)

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
por: Thilakasiri, Pathum, et al.
Publicado: (2019)

Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
por: Sofogianni, Areti, et al.
Publicado: (2020)

A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
por: Skat‐Rørdam, Josephine, et al.
Publicado: (2019)

Targeting Super-Enhancers for Disease Treatment and Diagnosis
por: Shin, Ha Youn
Publicado: (2018)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6its5cf92oe8c27mpq7ogh0ufj